A detailed history of Sapient Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sapient Capital LLC holds 255,495 shares of ABBV stock, worth $44.8 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
255,495
Previous 249,237 2.51%
Holding current value
$44.8 Million
Previous $42.7 Million 18.03%
% of portfolio
1.02%
Previous 0.9%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $1.03 Million - $1.25 Million
6,258 Added 2.51%
255,495 $50.5 Million
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $2.9 Million - $3.39 Million
-18,767 Reduced 7.0%
249,237 $42.7 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $8.84 Million - $10.1 Million
-55,328 Reduced 17.11%
268,004 $48.8 Billion
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $4.34 Million - $4.89 Million
31,526 Added 10.8%
323,332 $50.1 Billion
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $40.2 Million - $45.2 Million
291,806 New
291,806 $45.2 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.